ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $44 | -95.9% | 32 | -93.0% | 0.00% | – |
| Q1 2023 | $1,076 | -88.2% | 456 | -88.6% | 0.00% | – |
| Q4 2022 | $9,102 | +203.4% | 3,992 | +293.7% | 0.00% | – |
| Q3 2022 | $3,000 | -72.7% | 1,014 | -78.1% | 0.00% | – |
| Q2 2022 | $11,000 | -31.2% | 4,638 | +27.5% | 0.00% | – |
| Q4 2021 | $16,000 | – | 3,638 | +6514.5% | 0.00% | – |
| Q3 2021 | $0 | – | 55 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 55 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |